Ann: SMX Collaboration agreement with BASF, page-184

Hey Glyco good questions, I’m off to work so can’t reply in detail until tonight, Quanta might give you his POV though - He’s much smarter than me

However, I’m not valueing this one normally as it is a disrupting technology that can penetrate horizontally across different markets and vertically by targeting upstream tier 1s - This simply matters due to growth potential. Revenue projection is difficult as I don’t know enough about the sales model i.e what is the product costing and margin and how much is the SaaS worth in revenue also. When we get our first real commercial agreement I think we can model out future values more accuarately as current revenue (40k) is just from some trialing we are doing I believe. It is my opinion that SMX can impact its targets market significantly though - it is a one of a kind company

p.s company has some immediate revenue targets for performance rights, 1m$, 2m$ and 4m$ from memory

GL